Karyopharm Therapeutics (KPTI)
(Delayed Data from NSDQ)
$0.96 USD
+0.01 (1.43%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $0.97 +0.01 (1.01%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.29 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | 3.03% |
ABR | 1.43 |
Earnings ESP
|
8.62% |
---|---|
Current Year | -1.16 |
Next Year | -0.80 |
EPS (TTM) | -1.27 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 36.07M | 38.33M | 146.05M | 174.54M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 38.11M | 40.21M | 148.71M | 209.72M |
Low Estimate | 33.60M | 36.40M | 140.10M | 133.90M |
Year ago Sales | 37.58M | 36.01M | 146.03M | 146.05M |
Year over Year Growth Est. | -4.02% | 6.45% | 0.01% | 19.50% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.29 | -0.27 | -1.16 | -0.80 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.33 | -0.30 | -1.29 | -1.18 |
High Estimate | -0.20 | -0.19 | -0.87 | -0.57 |
Low Estimate | -0.33 | -0.31 | -1.29 | -1.18 |
Year ago EPS | -0.29 | -0.30 | -1.25 | -1.16 |
Year over Year Growth Est. | 0.00% | 10.00% | 7.20% | 30.60% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 2 | 2 | 2 | 2 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.29 | -0.27 | -1.16 | -0.80 |
7 Days Ago | -0.31 | -0.30 | -1.24 | -0.89 |
30 Days Ago | -0.32 | -0.30 | -1.25 | -0.90 |
60 Days Ago | -0.32 | -0.30 | -1.25 | -0.88 |
90 Days Ago | -0.31 | -0.30 | -1.19 | -1.05 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.27 | -0.25 | -1.08 | -0.91 |
Zacks Consensus Estimate | -0.29 | -0.27 | -1.16 | -0.80 |
Earnings ESP | 8.62% | 10.09% | 6.49% | -13.13% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.36 | -0.30 | -0.29 | NA |
Estimate | -0.33 | -0.29 | -0.28 | -0.34 | NA |
Difference | 0.01 | -0.07 | -0.02 | 0.05 | -0.01 |
Surprise | 3.03% | -24.14% | -7.14% | 14.71% | -3.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more